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Abstract
Cocaine is a widely used drug and its abuse is associated with physical, psychiatric and social problems. Abnormalities in
newborns have been demonstrated to be due to the toxic effects of cocaine during fetal development. The mechanism by
which cocaine causes neurological damage is complex and involves interactions of the drug with several neurotransmitter
systems, such as the increase of extracellular levels of dopamine and free radicals, and modulation of transcription factors. The
aim of this review was to evaluate the importance of the dopaminergic system and the participation of inflammatory signaling in
cocaine neurotoxicity. Our study showed that cocaine activates the transcription factors NF-kB and CREB, which regulate
genes involved in cellular death. GBR 12909 (an inhibitor of dopamine reuptake), lidocaine (a local anesthetic), and dopamine
did not activate NF-kB in the same way as cocaine. However, the attenuation of NF-kB activity after the pretreatment of the
cells with SCH 23390, a D1 receptor antagonist, suggests that the activation of NF-kB by cocaine is, at least partially, due to
activation of D1 receptors. NF-kB seems to have a protective role in these cells because its inhibition increased cellular death
caused by cocaine. The increase in BDNF (brain-derived neurotrophic factor) mRNA can also be related to the protective role
of both CREB and NF-kB transcription factors. An understanding of the mechanisms by which cocaine induces cell death in the
brain will contribute to the development of new therapies for drug abusers, which can help to slow down the progress of
degenerative processes.
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Introduction
Drug abuse and addiction constitute a public health
problem of great importance: both affect many people and
cause a wide variety of consequences to society. Cocaine
is an abused drug with a high prevalence worldwide.
According to the United Nations Office on Drugs and
Crime (UNODC, 2011 ,http://www.unodc.org/documents/
data-and-analysis/WDR2011/World_Drug_Report_2011_
ebook.pdf.), although cocaine use has declined, it is still
one of the most abused drugs in the USA. Cocaine inhibits
the dopamine transporter (DAT) in neuron terminals,
causing an increase in extracellular dopamine levels.
Activation of dopamine transmission in the mesocortico-
limbic system is a common characteristic of all addictive
drugs. This system originates in the ventral tegmental area
(VTA) and projects mainly to the nucleus accumbens (NAc)
and prefrontal cortex (PFC). Repeated exposure to
cocaine leads to neuroadaptations in themesocorticolimbic
system that are associated with the development of
addiction (1,2). Addiction is a chronic relapsing disease
(3) and its treatment is the most expensive of the
neuropsychiatric disorders (4), mainly owing to the costs
of health care, productivity loss, and crime (UNODC,
2011).
Cocaine Toxicity
Cocaine users seek the effects of euphoria (feeling of
well-being), self-confidence, and increased alertness.
However, cocaine abuse can also lead to adverse effects
such as anxiety, paranoia, self-centered behavior, dys-
phoria, and delusions (5). Moreover, many studies have
demonstrated a variety of toxic effects of cocaine in
humans (5-8) and animals (9,10). A study of 332 cocaine
users in Sa˜o Paulo found that one-fifth had severe
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seizures and death resulting from its chronic use (11). It
has also been demonstrated that the use of high doses of
cocaine is associated with violent behavior, including
murder and suicide (12). The stimulant effects of cocaine
can lead to a rapid increase in its intensity due to a
sensitization process related to drug craving and
increased intake, leading to the use of increasing
concentrations of the drug by chronic users (13). There
are reports that cocaine causes cardiovascular, neuro-
muscular, and central nervous system toxicity, and
complications such as infections, kidney and lung injury,
liver toxicity, and reproductive disorders (14). The
occurrence of epilepsy and psychiatric and neurological
deficits is also related to the use of this drug (15). Cocaine
can affect cellular morphology or function, including:
inhibition of neurite extension (extensions of the cell
bodies of neurons) (16), changes in the function and
morphology of mitochondria (17), reduced dilation of the
endoplasmic reticulum (18), and abnormal lysosomal
proteolysis (19). Cognitive disorders such as learning
and memory deficits are reported in most chronic users of
cocaine (20-22) and in children of dependent mothers (23-
25). Prenatal exposure to cocaine (26,27) may affect fetal
development because cocaine is able to cross the
placenta (28) and accumulate in the fetus (29,30). The
consequences - for developing neurons - of in utero
exposure to psychostimulants are regarded as a major
area of interest. It is estimated that approximately 30,000-
160,000 newborns are exposed to cocaine in utero per
year (Mathias, 1995 ,http://archives.drugabuse.gov/
NIDA_Notes/NNVol10N1/NIDASurvey.html.). However,
the consequences of prenatal cocaine use and the
mechanism of action by which this drug exerts its effects
have not been widely investigated. It has been reported
that newborns exposed to cocaine in utero tend to have low
birth weight, decreased head circumference, systemic
hypertension, tachycardia (31,32), and deficits in cognitive
development (33,34). The cognitive abnormalities detected
in the first year of life appear to contribute to learning and
attention disabilities at school age (35). The changes
associated with intrauterine exposure to cocaine may be
related to molecular adaptations or to anatomical changes
in specific brain regions, such as the anterior cingulate
cortex, prefrontal cortex, and middle frontal areas that
regulate cognitive and emotional development (25).
In vitro studies investigating the effects of cocaine in
cell culture neuroglioblastomas (36), PC12 cells (37),
cortical neurons of fetal mice (38), and neuronal precursor
cells (39) have reported changes in the growth and
differentiation of neurons and in the activation of cell
death pathways. In addition, it has been reported in
animal studies that prenatal exposure to cocaine causes
morphological brain abnormalities and cognitive deficits
after birth (34,40). Taken together, these data suggest
that cocaine can cause a variety of adverse effects on
neuronal development.
Cocaine effects on CREB and NF-kB
The induction by cocaine of the immediate expression
of genes involved in apoptotic cascades has been
reported by several researchers and it is believed that
this effect is mediated primarily by the stimulation of D1
receptors (41,42). Thus, it is suggested that cocaine
causes changes in gene transcription that can be
associated with some long-lasting functional changes
(43). CREB is a transcription factor that can be
phosphorylated by several protein kinases. CREB pro-
teins comprise a family that binds to a particular sequence
of DNA, called the cAMP response element (CRE) (44).
Activation of CREB involves several steps; the phosphor-
ylation of serine 133 (45) and the recruitment of CREB-
binding protein (CBP) are crucial (46,47). CREB plays an
important role in mediating the effects of cAMP and
neurotransmitters that act on gene expression via the
cAMP pathway. Some of the genes that contain CRE sites
express Fos, proencephalin, somatostatin, tyrosine
hydroxylase, a1-Na, K-ATPase, and vasoactive intestinal
peptide (48,49). The activation of the cAMP pathway is
regulated by the dopaminergic system, so the transcrip-
tion factor CREB seems to be involved in the effects of
chronic administration of psychostimulants (50).
NF-kB plays an important role in regulating the
inflammatory response and cell death (51). NF-kB is a
transcription factor found in a variety of cell types,
including neurons and microglia (52). NF-kB can be
activated by pro-inflammatory stimuli such as: pathogen-
derived lipopolysaccharide (LPS); cytokines, including
tumor necrosis factor-alpha (TNF-a) and interleukin-1 b
(IL-1b); and reactive oxygen species (53-55).
NF-kB proteins comprise members of the Rel/NF-kB
family, forming homo- and heterodimers through a
combination of the p65 (or RelA), p50, p52, c-Rel, or
RelB subunits. It is constitutively expressed in the
cytoplasm where it is bound to IkB, a protein that masks
the nuclear localization signal of NF-kB, thereby retaining
it in the cytoplasm (56). Inducers of NF-kB act through
intracellular signaling cascades that activate the IkB
kinases (IKKs), which phosphorylate two specific N-
terminal serines of IkBa, resulting in IkBa polyubiquitina-
tion and degradation in the 26S proteasome (57).
When IkBa is degraded, NF-kB migrates to the
nucleus and modulates the transcription of target genes
involved in cell death. Evidence obtained in our laboratory
showed, by electrophoretic mobility shift assay, that
1.0 mM cocaine induced activation of NF-kB in PC12
cells after 6 h of incubation (58). The activation of the p50/
p65 subunit of NF-kB by cocaine is linked to the activation
of the D1 dopamine receptor (58). Cocaine concentrations
used in our study were similar to those previously used by
others in different cell types (59,60). Cocaine-induced NF-
kB activation was also observed in macrophages (61),
human brain endothelial cells (62), and PC12 cells (63). In
addition, in vivo studies in mice showed that chronic
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administration of cocaine induced NF-kB activation in NAc
(64). It is important to note that high constitutive NF-kB
activity mediates resistance to oxidative stress in neuronal
cells (65) and in agents that inhibit NF-kB activation-
induced apoptosis in response to several neurotoxins
(66,67). In fact, in our study, the inhibition of NF-kB
significantly increased cell death accelerated by cocaine
treatment, suggesting that this transcription factor plays a
protective role in cocaine-treated PC12 cells (58). In
addition, Lee et al. (62) showed an anti-apoptotic effect of
NF-kB in PC12 cell death induced by auto-oxidized
dopamine. Taken together, the results showed that
concentrations of cocaine comparable to the concentra-
tion that has been reported in plasma levels (0.3 mM to
1 mM) of subjects who use this drug (60,68) can induce
changes in transcription factors that are important to the
inflammatory response and innate immune response (69)
and to cell death and the cell protection response.
Cell Death and Cocaine
Cell death can occur by two distinct mechanisms:
necrosis and apoptosis. Necrosis, also called pathological
or accidental cell death, occurs when cells are exposed to
an extreme variation of their physiological conditions
(such as hyperthermia and hypoxia) with consequent
damage of the membrane, leading to cell death.
Apoptosis, unlike necrosis, is a selective and regulated
process important for embryogenesis, development, and
the depletion of infected cells. However, a change in the
process of apoptosis can lead to the development of
some neurodegenerative diseases such as stroke,
Alzheimer’s disease, and Parkinson’s disease (70).
Given the diversity of situations that can cause
neuronal death by apoptosis, it is not surprising that
several components of signal transduction have been
described that participate in this process. Among them is
the loss of growth factors with neurotrophic activity such
as neuronal growth factor (71), which can be caused by
an increased release of cytokines such as TNF-a (72), the
excitotoxicity caused by an excessive increase in the
concentration of excitatory amino acids such as glutamate
(73), or by the increased oxidative stress and modulation
of transcription factors such as NF-kB (74).
In nervous tissue, apoptosis and necrosis may coexist
or occur sequentially, with the mode of cell death being
influenced by the intensity and duration of harmful stimuli
and also by the energy state of the cell (75). One way to
induce apoptosis is by the release of mitochondrial
cytochrome c and the subsequent activation of caspases
3, 6, and 7 (76).
In addition to the caspase-dependent apoptotic pro-
cess, caspase-independent events may also occur (77).
One of the most studied proteins involved in apoptosis is
caspase-independent apoptosis-inducing factor, which,
when released from mitochondria, translocates to the
nucleus, where it induces DNA fragmentation independent
of caspases. The proteins that form part of the Bcl-2 family
(Bax, Bak, Bcl-XL, Bcl-2, and others) regulate programmed
cell death, the integrity of the mitochondria, and cyto-
chrome c release (78). By acting on mitochondria, these
proteins have an important role in determining death and
cell survival (79). The Bax protein is considered pro-
apoptotic and the Bcl-2 protein anti-apoptotic (60). The
expression of Bcl-2 is increased in neurons that survived
ischemic strokes, and a reduction in this protein exacer-
bates neuronal death (80). The expression of Bcl-2 can be
induced by several promoters that bind to its regulatory
region, including CREB (81). Thus, the Bcl-2/Bax balance
is crucial to the regulation of cell death.
Brain-derived neurotrophic factor (BDNF) is a neuro-
trophin that plays an important role in neuronal protection.
The intracellular signaling of BDNF occurs by the binding
of neurotrophin to its receptor TrkB and by the activation
of protein tyrosine kinases in the cytoplasm (82). BDNF is
regulated by many factors, including transcription factors
such as NF-kB and CREB. These, too, are indirectly
regulated by the expression of the receptor TrkB, which
requires the presence of secondary events such as
increased cAMP or Ca2+ to be efficiently inserted in the
plasma membrane, thereby being able to transduce the
signal triggered by the binding of BDNF (83).
Several reports suggest that cell death by apoptosis
plays an important role in the induction of neuronal loss
caused by cocaine and other psychostimulants (84,85). It
has been shown that cocaine activates the mitochondrial
apoptotic pathway, decreasing the levels of mitochondrial
cytochrome c and activating caspases 3 and 9 in cultured
neuronal cortex (59). In myocardial cells, cocaine inhibits
a complex of the respiratory chain of mitochondria (68)
and decreases the mitochondrial membrane potential and
ATP levels in cardiomyocytes (86). Finally, the results of
microarray experiments (87) suggest that mitochondrial
function and energy metabolism are affected in the brains
of cocaine human abusers.
We confirmed that cocaine treatment induced PC12
cell death by apoptosis and that necrosis was associated
with mitochondrial dysfunction, increased LDH release,
activation of caspase 3, decreased Bcl-2 expression, and
increased a-spectrin cleavage. In our experiments, we
found an increase in BDNF mRNA levels 6 h after
treatment with cocaine, indicating a transitory rise in this
neurotrophin. BDNF regulates the differentiation and
apoptosis of neurons and glial cells (88), and the increase
in BDNF may be considered as a line of defense against
the apoptosis process caused - in our model - by cocaine.
In fact, the increase in BDNF mRNA levels could be linked
to the activation of NF-kB and CREB (89). The protective
role of NF-kB in cocaine treatment of PC12 cells may be
associated with the expression of anti-apoptotic genes,
such as BDNF. However, the compensatory mechanisms
for cell death induced by cocaine are ineffective at
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terminating the apoptosis process later (Figure 1). It is
interesting to note that methamphetamine and 3,4-
methylenedioxymethamphetamine can also induce apop-
tosis in the same way as cocaine, but cocaine seems to
be less toxic (84). This may be due to the induction of
protective systems (e.g., NF-kB and BDNF) by cocaine.
Therefore, the activation of both transcription factors may
represent a compensatory mechanism to limit cell death
associated with cocaine drug abuse.
Although we have considered the induction of apopto-
sis related to mitochondrial dysfunction as the prime
pathway involved in cocaine neurotoxicity, it is important
to consider other alternative pathways that can also play an
important role in this process, such as the NADPH oxidase
pathway. In fact, cocaine is associated with severe
oxidative stress in cardiomyocytes involving the production
of reactive oxygen species, leading to MAPK activation
and an apoptosis process that is mediated by NOX2 (90).
An understanding of the mechanisms by which cocaine
induces cell death in the brain will contribute to the
development of new therapies designed to slow the
progress of neurodegenerative processes in drug abusers.
Cocaine can cause damage to the newborn children of
pregnant women who use cocaine during the pregnancy.
As the migration behavior of neurons ultimately deter-
mines their connectivity, synaptic potential, and success
of neurotransmission, cocaine may produce behavioral
and anatomical alterations as a result of maternal cocaine
use during pregnancy by acting on neuronal guidance. An
understanding of the mechanisms by which cocaine leads
to motivational alterations in offspring may ultimately pave
the way for the development of strategies for educational
intervention programs and/or potential pharmacological
treatments.
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